Q2 2025 Holdings
Filed 2025-08-13 | 20 holdings | $63.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $11.6M | 368,665 | 18.4% |
| Illumina Inc(ILMN) | COM | 452327109 | $11.4M | 119,196 | 17.9% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $10.0M | 514,702 | 15.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.0M | 59,022 | 6.3% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $3.8M | 15,722 | 6.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.6M | 11,872 | 5.7% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $3.4M | 664,610 | 5.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $3.1M | 49,120 | 4.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.3M | 13,600 | 3.7% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $2.3M | 1,883,179 | 3.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.2M | 102,984 | 3.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.5M | 2,800 | 2.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $1.3M | 30,875 | 2.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $708.3K | 19,253 | 1.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $592.0K | 63,719 | 0.9% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $479.2K | 68,943 | 0.8% |
| Bolt Biotherapeutics Inc(BOLT) | COM NEW | 097702203 | $336.7K | 58,347 | 0.5% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $329.8K | 49,082 | 0.5% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $253.7K | 493,584 | 0.4% |
| Bolt Projs Hldgs Inc(BSLK) | COM NEW | 09769B206 | $114.5K | 40,597 | 0.2% |